![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Ambion Announces Continued Alliance With Wyeth
Ambion Announces Continued Alliance With Wyeth
Ambion Diagnostics, a division of Ambion, has entered into a new agreement with Wyeth Pharmaceuticals to continue its alliance in the development and supply of cGMP-grade RNA that will be incorporated as a component in Wyeth's innovative vaccine program. Ambion Diagnostics will manufacture RNA transcripts according to QSR guidelines and will supply the material at a scale sufficient to meet Wyeth's requirements for Phase I/II clinical trials.
Austin dBusiness News (http://austin.dbusinessnews.com/shownews.php?newsid=13978&type_news=latest)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct